Outset Medical, Inc. (OM) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $19.00K; Additional Paid in Capital, Common StockUSD $1.30B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-136.00K.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $18.00K; Additional Paid in Capital, Common StockUSD $1.30B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-73.00K.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $18.00K; Additional Paid in Capital, Common StockUSD $1.30B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $172.00K.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $3.84M; Common Stock, Value, IssuedUSD $18.00K; Additional Paid in Capital, Common StockUSD $1.29B; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $157.00K.
Outset Medical, Inc. Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Increase in Carrying Amount of Redeemable Preferred Stock USD |
|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $19.00K | $1.30B | $-136.00K | $-1.21B | $96.34M | 3 month · $2.70M | (m) |
| 2026-03-31 | $0.00 | $18.00K | $1.30B | $-73.00K | $-1.19B | $111.69M | 3 month · $3.45M | (m) |
| 2025-12-31 | $0.00 | $18.00K | $1.30B | $172.00K | $-1.17B | $126.95M | 12 month · $15.62M | (m) |
| 2025-09-30 | $3.84M | $18.00K | $1.29B | $157.00K | $-1.15B | $142.37M | 3 month · $5.08M | (m) |
| 2025-06-30 | $3.84M | $18.00K | $1.28B | $49.00K | $-1.13B | $154.78M | 3 month · $3.50M | (m) |
| 2025-03-31 | $3.84M | $18.00K | $1.28B | $88.00K | $-1.12B | $169.87M | 3 month · $2.98M | (m) |
| 2024-12-31 | $0.00 | $4.00K | $1.12B | $42.00K | $-1.09B | $26.82M | 12 month · $29.36M | (m) |
| 2024-09-30 | $0.00 | $52.00K | $1.11B | $352.00K | $-1.06B | $47.82M | 3 month · $6.39M | (m) |
| 2024-06-30 | $0.00 | $52.00K | $1.10B | $-302.00K | $-1.04B | $68.60M | 3 month · $9.82M | (m) |
| 2024-03-31 | $0.00 | $52.00K | $1.10B | $-258.00K | $-1.00B | $93.20M | 3 month · $8.20M | (m) |
| 2023-12-31 | $0.00 | $50.00K | $1.08B | $68.00K | $-961.75M | $122.89M | 12 month · $38.63M | (m) |
| 2023-09-30 | $0.00 | $50.00K | $1.08B | $-253.00K | $-923.15M | $152.06M | 3 month · $10.89M | (m) |
| 2023-06-30 | $0.00 | $50.00K | $1.06B | $-393.00K | $-876.97M | $183.11M | 3 month · $10.11M | (m) |
| 2023-03-31 | $0.00 | $49.00K | $1.05B | $-113.00K | $-832.92M | $216.29M | 3 month · $8.54M | (m) |
| 2022-12-31 | $0.00 | $48.00K | $1.04B | $-564.00K | $-788.95M | $245.99M | 12 month · $27.20M | (m) |
| 2022-09-30 | $0.00 | $48.00K | $1.03B | $-934.00K | $-747.51M | $279.10M | 3 month · $7.43M | (m) |
| 2022-06-30 | $0.00 | $48.00K | $1.02B | $-955.00K | $-706.73M | $309.76M | 3 month · $7.41M | (m) |
| 2022-03-31 | $0.00 | $48.00K | $1.01B | $-649.00K | $-662.89M | $345.45M | 3 month · $5.01M | (m) |
| 2021-12-31 | $0.00 | $47.00K | $1.00B | $-184.00K | $-625.99M | $374.08M | 12 month · $17.45M | (m) |
| 2021-09-30 | $0.00 | $47.00K | $994.49M | $-20.00K | $-584.76M | $409.75M | 3 month · $2.86M | (m) |
| 2021-06-30 | (m) | $46.00K | $985.44M | $-28.00K | $-554.29M | $431.16M | 3 month · $3.94M | (m) |
| 2021-03-31 | (m) | $43.00K | $830.69M | $-8.00K | $-524.08M | $306.64M | 3 month · $5.85M | (m) |
| 2020-12-31 | $0.00 | $43.00K | $822.62M | $1.00K | $-494.06M | $328.61M | 12 month · $21.44M | 12 month · $362.00K |
| 2020-09-30 | (m) | $42.00K | $816.31M | $1.00K | $-462.02M | $354.33M | 3 month · $13.91M | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | $-334.08M | 3 month · $683.00K | (m) |
| 2020-03-31 | (m) | (m) | (m) | (m) | (m) | $-308.35M | 3 month · $580.00K | 3 month · $362.00K |
| 2019-12-31 | (m) | $1.00K | $357.00K | $22.00K | $-372.57M | $-372.19M | 12 month · $883.00K | 12 month · $134.76M |
| 2019-09-30 | (m) | (m) | (m) | (m) | (m) | $-353.08M | 3 month · $236.00K | 3 month · $118.86M |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | $-336.48M | 3 month · $161.00K | 3 month · $8.03M |
| 2019-03-31 | (m) | (m) | (m) | (m) | (m) | $-311.77M | 3 month · $239.00K | 3 month · $7.87M |
| 2018-12-31 | (m) | (m) | (m) | (m) | (m) | $-287.95M | 12 month · $788.00K | 12 month · $23.30M |
| 2017-12-31 | (m) | (m) | (m) | (m) | (m) | $-215.94M | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PRECISION OPTICS CORPORATION, INC. (POCI) | United States | $0.052B | |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B |